Functional variants of glucokinase regulatory protein and apolipoprotein A5 genes in ischemic stroke

Journal of Molecular Neuroscience

Volumn 41, Issue 1, 2010, Pages 121-128

  Járomi, Luca ^a   Csöngei, Veronika ^a   Polgár, Noémi ^a   Szolnoki, Zoltán ^b   Maász, Anita ^a   Horvatovich, Katalin ^a   Faragó, Bernadett ^a   Sipeky, Csilla ^a   Sáfrány, Eniko ^a   Magyari, Lili ^a   Kisfali, Péter ^a   Mohás, Márton ^c   Janicsek, Ingrid ^a   Lakner, Lilla ^d   Melegh, Béla ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Pandy Kalman County Hospital   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d Markusovszky Teaching Hospital   (Hungary)

Author keywords

APOA5; GCKR; Stroke; Triglyceride

Indexed keywords

APOLIPOPROTEIN A5; GLUCOKINASE; REGULATOR PROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 77950189510     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-009-9301-9     Document Type: Article

References (37)

1. S Bansal JE Buring N Rifai S Mora FM Sacks PM Ridker 2007 Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women JAMA 298 309 316 10.1001/jama.298.3.309 1:CAS:528:DC%2BD2sXotValtb0%3D 17635891 (Pubitemid 47080485)
2. D Farrelly KS Brown A Tieman, et al. 1999 Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: a sequestration mechanism in metabolic regulation Proc Natl Acad Sci USA 96 14511 14516 10.1073/pnas.96.25.14511 1:CAS:528:DyaK1MXnvFKks70%3D 10588736 (Pubitemid 30000681)
3. JJ Freiberg A Tybjaerg-Hansen JS Jensen BG Nordestgaard 2008 Nonfasting triglycerides and risk of ischemic stroke in the general population JAMA 300 2142 2152 10.1001/jama.2008.621 1:CAS:528:DC%2BD1cXhtlOrtb7J 19001625
4. J Grimsby JW Coffey MT Dvorozniak, et al. 2000 Characterization of glucokinase regulatory protein-deficient mice J Biol Chem 275 7826 7831 10.1074/jbc.275.11.7826 1:CAS:528:DC%2BD3cXitVylsbg%3D 10713097 (Pubitemid 30159689)
5. M Groenendijk RM Cantor TW De Bruin GM Dallinga-Thie 2001 The apoAI-CIII-AIV gene cluster Atherosclerosis 157 1 11 10.1016/S0021-9150(01) 00539-1 1:CAS:528:DC%2BD3MXksVGktbs%3D 11427198 (Pubitemid 32539348)
6. V Hachinski C Graffagnino M Beaudry, et al. 1996 Lipids and stroke: a paradox resolved Arch Neurol 53 303 308 1:STN:280:DyaK283gtVagug%3D%3D 8929151
7. LL Haheim I Holme I Hjermann P Leren 1993 Risk factors of stroke incidence and mortality. a 12-year follow-up of the Oslo Study Stroke 24 1484 1489 1:STN:280:DyaK3szpt1WksA%3D%3D 8378951
8. V Havasi Z Szolnoki G Talian, et al. 2006 Apolipoprotein A5 gene promoter region T-1131C polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke J Mol Neurosci 29 177 183 10.1385/JMN:29:2:177 1:CAS:528:DC%2BD28XosVKmsbw%3D 16954607 (Pubitemid 44352541)
9. BE Hayward JA Fantes JP Warner, et al. 1996 Co-localization of the ketohexokinase and glucokinase regulator genes to a 500-kb region of chromosome 2p23 Mamm Genome 7 454 458 10.1007/s003359900132 1:CAS:528:DyaK28XksF2qur4%3D 8662230
10. BE Hayward N Dunlop S Intody, et al. 1998 Organization of the human glucokinase regulator gene GCKR Genomics 49 137 142 10.1006/geno.1997.5195 1:CAS:528:DyaK1cXivFSmtLY%3D 9570959 (Pubitemid 28194447)
11. S Kathiresan O Melander D Anevski, et al. 2008 Polymorphisms associated with cholesterol and risk of cardiovascular events N Engl J Med 358 1240 1249 10.1056/NEJMoa0706728 1:CAS:528:DC%2BD1cXjvVWmsLc%3D 18354102
12. S Kathiresan O Melander C Guiducci, et al. 2008 Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans Nat Genet 40 189 197 10.1038/ng.75 1:CAS:528:DC%2BD1cXhtl2qsL0%3D 18193044
13. A Maasz P Kisfali L Jaromi, et al. 2008 Apolipoprotein A5 gene IVS3+G476A allelic variant confers susceptibility for development of ischemic stroke Circ J 72 1065 1070 10.1253/circj.72.1065 1:CAS:528:DC%2BD1cXovFeltrs%3D 18577813
14. A Maasz P Kisfali Z Szolnoki F Hadarits B Melegh 2008 Apolipoprotein A5 gene C56G variant confers risk for the development of large vessel associated ischemic stroke J Neurol 255 649 654 10.1007/s00415-008-0768-z 1:CAS:528:DC%2BD1cXovVersLs%3D 18274806
15. N Martinelli D Girelli P Ferraresi, et al. 2007 Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism Blood Coagul Fibrinolysis 18 125 129 10.1097/MBC.0b013e328011c06d 1:CAS:528:DC%2BD2sXhsVSisb8%3D 17287628 (Pubitemid 46232832)
16. N Martinelli E Trabetti A Bassi, et al. 2007 The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study Atherosclerosis 191 409 417 10.1016/j.atherosclerosis.2006.04.009 1:CAS:528:DC%2BD2sXjtFGqsrk%3D 16682041 (Pubitemid 46400704)
17. SA Miller DD Dykes HF Polesky 1988 A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 16 1215 10.1093/nar/16.3.1215 1:CAS:528:DyaL1cXhsVKlsrs%3D 3344216
18. AC Morrison LA Bare LE Chambless, et al. 2007 Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis risk in communities study Am J Epidemiol 166 28 35 10.1093/aje/kwm060 17443022 (Pubitemid 47234300)
19. BG Nordestgaard M Benn P Schnohr A Tybjaerg-Hansen 2007 Non-fasting triglycerides and risk of for myocardial infarction and death among women and men Ugeskr Laeger 169 3865 3868 18031660
20. LA Pennacchio EM Rubin 2003 Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice Arterioscler Thromb Vasc Biol 23 529 534 10.1161/01.ATV.0000054194.78240.45 1:CAS:528: DC%2BD3sXisFKgt7Y%3D 12615678 (Pubitemid 36438063)
21. P Perez-Martinez D Corella J Shen, et al. 2009 Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states Am J Clin Nutr 89 391 399 10.3945/ajcn.2008.26363 1:CAS:528:DC%2BD1MXnsFKluw%3D%3D 19056598
22. PM Rothwell AJ Coull LE Silver, et al. 2005 Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study) Lancet 366 1773 1783 10.1016/S0140-6736(05)67702-1 1:STN:280:DC%2BD2Mnhsl2nsg%3D%3D 16298214 (Pubitemid 41642641)
23. JT Salonen P Puska J Tuomilehto K Homan 1982 Relation of blood pressure, serum lipids, and smoking to the risk of cerebral stroke. A longitudinal study in Eastern Finland Stroke 13 327 333 1:STN:280:DyaL383gtVenuw%3D%3D 7080126
24. R Saxena BF Voight V Lyssenko, et al. 2007 Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels Science 316 1331 1336 10.1126/science.1142358 1:CAS:528:DC%2BD2sXmtVyitrk%3D 17463246 (Pubitemid 46871653)
25. LA Simons J McCallum Y Friedlander J Simons 1998 Risk factors for ischemic stroke: Dubbo study of the elderly Stroke 29 1341 1346 1:STN:280:DyaK1czitFyhsw%3D%3D 9660384
26. C Szalai M Keszei J Duba, et al. 2004 Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease Atherosclerosis 173 109 114 10.1016/j. atherosclerosis.2003.12.003 1:CAS:528:DC%2BD2cXht1yrt7Y%3D 15177130 (Pubitemid 38224202)
27. Z Szolnoki F Somogyvari A Kondacs, et al. 2003 Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke J Neurol Neurosurg Psychiatry 74 1615 1620 10.1136/jnnp.74.12.1615 1:STN:280:DC%2BD3srpsFGgsQ%3D%3D 14638877 (Pubitemid 37542048)
28. A Trichopoulou N Yiannakouris C Bamia V Benetou D Trichopoulos JM Ordovas 2008 Genetic predisposition, nongenetic risk factors, and coronary infarct Arch Intern Med 168 891 896 10.1001/archinte.168.8.891 18443266
29. SF Vaessen FG Schaap JA Kuivenhoven, et al. 2006 Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk population study J Lipid Res 47 2064 2070 10.1194/jlr.M600233-JLR200 1:CAS:528:DC%2BD28Xpt1GjsL4%3D 16769999 (Pubitemid 44401995)
30. M Vaxillaire N Vionnet C Vigouroux, et al. 1994 Search for a third susceptibility gene for maturity-onset diabetes of the young. Studies with eleven candidate genes Diabetes 43 389 395 10.2337/diabetes.43.3.389 1:CAS:528:DyaK2cXlslWltb0%3D 7508874
31. M Vaxillaire C Cavalcanti-Proenca A Dechaume, et al. 2008 The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population Diabetes 57 2253 2257 10.2337/db07-1807 1:CAS:528: DC%2BD1cXps1Oisbw%3D 18556336
32. M Veiga-da-Cunha J Delplanque A Gillain, et al. 2003 Mutations in the glucokinase regulatory protein gene in 2p23 in obese French caucasians Diabetologia 46 704 711 1:CAS:528:DC%2BD3sXksFKmu7c%3D 12739015
33. JP Warner JP Leek S Intody AF Markham DT Bonthron 1995 Human glucokinase regulatory protein (GCKR): cDNA and genomic cloning, complete primary structure, and chromosomal localization Mamm Genome 6 532 536 10.1007/BF00356171 1:CAS:528:DyaK2MXnvV2qsbc%3D 8589523
34. CJ Willer S Sanna AU Jackson, et al. 2008 Newly identified loci that influence lipid concentrations and risk of coronary artery disease Nat Genet 40 161 169 10.1038/ng.76 1:CAS:528:DC%2BD1cXhtl2rsro%3D 18193043
35. WT Wright IS Young DP Nicholls C Patterson K Lyttle CA Graham 2006 SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population Atherosclerosis 185 353 360 10.1016/j.atherosclerosis.2005.06.043 1:CAS:528:DC%2BD28XitVKgtrs%3D 16125709 (Pubitemid 43306749)
36. Y Yang E Ruiz-Narvaez T Niu X Xu H Campos 2004 Genetic variants of the lipoprotein lipase gene and myocardial infarction in the Central Valley of Costa Rica J Lipid Res 45 2106 2109 10.1194/jlr.M400202-JLR200 1:CAS:528: DC%2BD2cXpsVSktrg%3D 15292372 (Pubitemid 40990905)
37. N Yiannakouris A Trichopoulou V Benetou T Psaltopoulou JM Ordovas D Trichopoulos 2006 A direct assessment of genetic contribution to the incidence of coronary infarct in the general population Greek EPIC cohort Eur J Epidemiol 21 859 867 10.1007/s10654-006-9070-5 17119879 (Pubitemid 46197151)